Cargando…
Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
BACKGROUND: The glucocorticoid receptor gene (NR3C1) encodes the receptor to which cortisol and other glucocorticoids bind. Steroids in either oral, intratympanic, or intravascular forms are the treatment of choice for sudden sensorineural hearing loss (SSNHL), but the outcome varies. The outcomes o...
Autores principales: | Chien, Chen-Yu, Tai, Shu-Yu, Li, Kuan-Hui, Yang, Hua-Ling, Wang, Ling-Feng, Ho, Kuen-Yao, Chang, Ning-Chia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926839/ https://www.ncbi.nlm.nih.gov/pubmed/36782309 http://dx.doi.org/10.1186/s40463-022-00601-w |
Ejemplares similares
-
The association of genetic polymorphisms in interleukin-1 receptors type 1 and type 2 with sudden sensorineural hearing loss in a Taiwanese population: a case control study
por: Chien, Chen-Yu, et al.
Publicado: (2021) -
Association of sudden sensorineural hearing loss with dementia: a nationwide cohort study
por: Tai, Shu-Yu, et al.
Publicado: (2021) -
Glucocorticoid influence on prognosis of idiopathic sudden sensorineural hearing loss()
por: Bogaz, Eduardo Amaro, et al.
Publicado: (2014) -
Correlations of MIF polymorphism and serum levels of
MIF with glucocorticoid sensitivity of sudden sensorineural hearing
loss
por: Zhu, Wen-Yan, et al.
Publicado: (2019) -
Clinical features and prognostic factors of children with profound sudden sensorineural hearing loss
por: Xiao, Ling, et al.
Publicado: (2022)